RnR Market Research Offers “Bioinformatics Partnering Terms and Agreements” Reportat US$ 2795 (Single User License). The r...
and their partners.The initial chapters of this report provide an orientation of bioinformatics dealmaking and businessact...
Bioinformatics Partnering Terms and Agreements includes:- Trends in bioinformatics dealmaking in the biopharma industry si...
Table of ContentExecutive SummaryChapter 1 – IntroductionChapter 2 – Trends in bioinformatics dealmakingChapter 3 – Leadin...
Upcoming SlideShare
Loading in...5
×

Bioinformatics Terms and Agreements 2013

102

Published on

Buy the report "Bioinformatics Partnering Terms and Agreements" at US $2795 for a Single User PDF License from RnR Market Research Reports Library. The report provides a detailed understanding and analysis of how and why companies enter bioinformatics partnering deals.

Published in: Health & Medicine
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
102
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
2
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Transcript of "Bioinformatics Terms and Agreements 2013"

  1. 1. RnR Market Research Offers “Bioinformatics Partnering Terms and Agreements” Reportat US$ 2795 (Single User License). The report got published in Mar 2013 & Contains 1154Pages.The Bioinformatics Partnering Terms and Agreements report provides comprehensive understanding andunprecedented access to the bioinformatics partnering deals and agreements entered into by the worldsleading healthcare companies.- Trends in bioinformatics partnering deals- Deal terms analysis- Partnering agreement structure- Partnering contract documents- Top deals by value- Most active dealmakers- Average deal terms for bioinformaticsThe Bioinformatics Partnering Terms and Agreements report provides comprehensive understanding andunprecedented access to the bioinformatics partnering deals and agreements entered into by the worldsleading healthcare companies.The report provides a detailed understanding and analysis of how and why companies enterbioinformatics partnering deals. The majority of deals are discovery stage whereby the licensee obtains aright or an option right to license the licensors bioinformatics technology. These deals tend to bemulticomponent, starting with collaborative R&D, and commercialization of outcomes.This report provides details of the latest bioinformatics agreements announced in the healthcare sectors.Bioinformatics is the application of computer science and information technology to the field of biologyand medicine. Bioinformatics deals with algorithms, databases, information systems, web technologies,artificial intelligence, information and computation theory, software engineering, data mining, imageprocessing, modeling, simulation, signal processing, discrete mathematics, control systems, andstatistics, for generating new knowledge of biology and medicine.Bioinformatics deals have increased in terms of popularity for partnering in the past decade, as computingpower has been embraced in order to speed up the discovery, evaluation and clinical assessmentprocesses.Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight intothe negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilstmany smaller companies will be seeking details of the payments clauses, the devil is in the detail in termsof how payments are triggered – contract documents provide this insight where press releases anddatabases do not.Request a Sample Copy @ http://www.rnrmarketresearch.com/contacts/request-sample?rname=82679This report contains a comprehensive listing of all bioinformatics partnering deals announced sinceJanuary 2007, including financial terms where available, including over 1500 links to online deal recordsof actual bioinformatics partnering deals as disclosed by the deal parties. In addition, where available,records include contract documents as submitted to the Securities Exchange Commission by companies
  2. 2. and their partners.The initial chapters of this report provide an orientation of bioinformatics dealmaking and businessactivities. Chapter 1 provides an introduction to the report, whilst chapter 2 provides an overview of thetrends in bioinformatics dealmaking since 2007, including details of average headline, upfront, milestoneand royalty terms.Chapter 3 provides a review of the leading bioinformatics deals since 2007. Deals are listed by headlinevalue, signed by bigpharma, most active bigpharma, and most active of all biopharma companies. Wherethe deal has an agreement contract published at the SEC a link provides online access to the contract.Chapter 4 provides a comprehensive listing of the top 50 bigpharma companies with a brief summaryfollowed by a comprehensive listing of bioinformatics deals, as well as contract documents available inthe public domain. Where available, each deal title links via Weblink to an online version of the actualcontract document, providing easy access to each contract document on demand.Chapter 5 provides a comprehensive and detailed review of bioinformatics partnering deals signed andannounced since January 2007, where a contract document is available in the public domain. Thechapter is organized by stage of development at signing, deal type (collaborative R&D, co-promotion,licensing etc), and specific therapy focus. Each deal title links via Weblink to an online version of the dealrecord and where available, the contract document, providing easy access to each contract document ondemand.In addition, a comprehensive appendix is provided organized by bioinformatics partnering company A-Z ,deal type definitions and bioinformatics partnering agreements example. Each deal title links via Weblinkto an online version of the deal record and where available, the contract document, providing easy accessto each contract document on demand.The report also includes numerous tables and figures that illustrate the trends and activities inbioinformatics partnering and dealmaking since 2007.In conclusion, this report provides everything a prospective dealmaker needs to know about partnering inthe research, development and commercialization of bioinformatics technologies and products.Bioinformatics Partnering Terms and Agreements provides the reader with the following keybenefits:- In-depth understanding of bioinformatics deal trends since 2007- Access to headline, upfront, milestone and royalty data- Analysis of the structure of bioinformatics agreements with numerous real life case studies- Comprehensive access to over 1500 actual vaccine contracts entered into by the world’s biopharmacompanies- Detailed access to actual bioinformatics contracts enter into by the leading fifty bigpharma companies- Insight into the terms included in a bioinformatics agreement, together with real world clause examples- Understand the key deal terms companies have agreed in previous deals- Undertake due diligence to assess suitability of your proposed deal terms for partner companiesReport scopeBioinformatics Partnering Terms and Agreements is intended to provide the reader with an in-depthunderstanding and access to bioinformatics trends and structure of deals entered into by leadingcompanies worldwide.
  3. 3. Bioinformatics Partnering Terms and Agreements includes:- Trends in bioinformatics dealmaking in the biopharma industry since 2007 Analysis of bioinformaticsdeal structure- Access theadline, upfront, milestone and royalty data Case studies of real-life bioinformatics dealsAccess tover 1500 bioinformatics contract documents- The leading bioinformatics deals by value since 2005 Most active bioinformatics dealmakers since 2007- The leading bioinformatics partnering resources In Bioinformatics Partnering Terms and Agreements,the available contracts are listed by: Company A-Z Headline value- Stage of development at signing Deal component type- Specific therapy target Each deal title links via Weblink tan online version of the deal record and whereavailable, the contract document, providing easy access teach contract document on demand.The Bioinformatics Partnering Terms and Agreements report provides comprehensive access tavailabledeals and contract documents for over 1,500 bioinformatics deals.Analyzing actual contract agreements allows assessment of the following:- What are the precise bioinformatics rights granted or optioned?- What is actually granted by the agreement tthe partner company?- What exclusivity is granted?- What is the payment structure for the deal? How are sales and payments audited?- What is the deal term?- How are the key terms of the agreement defined?- How are IPRs handled and owned? Whis responsible for commercialization?- Which responsible for development, supply, and manufacture?- How is confidentiality and publication managed? How are disputes tbe resolved?- Under what conditions can the deal be terminated? What happens when there is a change ofownership?- What sublicensing and subcontracting provisions have been agreed? Which boilerplate clauses doesthe company insist upon?- Which boilerplate clauses appear tdiffer from partner tpartner or deal type tdeal type?- Which jurisdiction does the company insist upon for agreement law?Number of pages: The report is comprised of two volumes with the second volume containing theappendices totaling 1154 pages.Bioinformatics Partnering Terms and Agreements provides the reader with the following keybenefits:- In-depth understanding of bioinformatics deal trends since 2007- Access to headline, upfront, milestone and royalty data- Analysis of the structure of bioinformatics agreements with numerous real life case studies- Comprehensive access to over 1500 actual bioinformatics contracts entered into by the world’sbiopharma companies- Detailed access to actual bioinformatics contracts enter into by the leading fifty bigpharma companies- Insight into the terms included in a bioinformatics agreement, together with real world clause examples- Understand the key deal terms companies have agreed in previous deals- Undertake due diligence to assess suitability of your proposed deal terms for partner companiesBuy a Report Copy @ http://www.rnrmarketresearch.com/contacts/purchase?rname=82679
  4. 4. Table of ContentExecutive SummaryChapter 1 – IntroductionChapter 2 – Trends in bioinformatics dealmakingChapter 3 – Leading bioinformatics dealsChapter 4 – Bigpharma bioinformatics dealsChapter 5 – Bioinformatics dealmaking directoryChapter 6 – Partnering resource centerAbout Wildwood VenturesFor more details contact Mr. Priyank Tiwari: sales@rnrmarketresearch.com / +18883915441Website: http://www.rnrmarketresearch.com/

×